Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan W Said

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2017
Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing SarcomaHaibo Sun, De-Chen Lin, Qi Cao, et al.
The American Journal of Surgical Pathology|November 2, 2020
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological TherapyAliyah R Sohani, Matthew J Maurer, Sharmila Giri, et al.
The Journal of Urology|November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international populationKen-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraftManoj Garg, Ryoko Okamoto, Yasunobu Nagata, et al.
Nucleic Acids Research|November 30, 2018
Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1Lehang Lin, Moli Huang, Xianping Shi, et al.
Nature Communications|March 24, 2019
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcomaYe Chen, Liang Xu, Anand Mayakonda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse modelsFrédéric D Birkhäuser, Richard C Koya, Caleb Neufeld, et al.
The Journal of Pathology|June 22, 2018
The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesisJin-Fen Xiao, Qiao-Yang Sun, Ling-Wen Ding, et al.
Oncogene|July 24, 2019
SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cellsQiao-Yang Sun, Ling-Wen Ding, Kara Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2013
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancersDe-Chen Lin, Liang Xu, Ling-Wen Ding, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2017
Identification of a Novel SYK/c-MYC/MALAT1 Signaling Pathway and Its Potential Therapeutic Value in Ewing SarcomaHaibo Sun, De-Chen Lin, Qi Cao, et al.
The American Journal of Surgical Pathology|November 2, 2020
Biomarkers for Risk Stratification in Patients With Previously Untreated Follicular Lymphoma Receiving Anti-CD20-based Biological TherapyAliyah R Sohani, Matthew J Maurer, Sharmila Giri, et al.
The Journal of Urology|November 25, 2003
Validation of an integrated staging system toward improved prognostication of patients with localized renal cell carcinoma in an international populationKen-Ryu Han, Ivar Bleumer, Allan J Pantuck, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2014
Establishment and characterization of novel human primary and metastatic anaplastic thyroid cancer cell lines and their genomic evolution over a year as a primagraftManoj Garg, Ryoko Okamoto, Yasunobu Nagata, et al.
Nucleic Acids Research|November 30, 2018
Super-enhancer-associated MEIS1 promotes transcriptional dysregulation in Ewing sarcoma in co-operation with EWS-FLI1Lehang Lin, Moli Huang, Xianping Shi, et al.
Nature Communications|March 24, 2019
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcomaYe Chen, Liang Xu, Anand Mayakonda, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 5, 2013
Dendritic cell-based immunotherapy in prevention and treatment of renal cell carcinoma: efficacy, safety, and activity of Ad-GM·CAIX in immunocompetent mouse modelsFrédéric D Birkhäuser, Richard C Koya, Caleb Neufeld, et al.
The Journal of Pathology|June 22, 2018
The c-MYC-BMI1 axis is essential for SETDB1-mediated breast tumourigenesisJin-Fen Xiao, Qiao-Yang Sun, Ling-Wen Ding, et al.
Oncogene|July 24, 2019
SOX7 regulates MAPK/ERK-BIM mediated apoptosis in cancer cellsQiao-Yang Sun, Ling-Wen Ding, Kara Johnson, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 29, 2013
Genomic and functional characterizations of phosphodiesterase subtype 4D in human cancersDe-Chen Lin, Liang Xu, Ling-Wen Ding, et al.
Pageof 13